|
시장보고서
상품코드
2075743
내장통 치료 시장 : 약제 유형별, 적응증별, 유통 채널별, 지역별Visceral Pain Treatment Market, By Drug Type By Indications and By Distribution Channels By Region |
||||||
내장통 치료 시장은 2026년에 170억 4,000만 달러 규모에 이를 것으로 추정되며, 2033년까지 254억 5,000만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR 5.9%로 성장할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 170억 4,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) : | 5.90% | 시장 규모 예측(2033년) : | 254억 5,000만 달러 |
내장통은 골반, 흉부 또는 복부의 내장(장기)에 있는 통각 수용체가 활성화됨으로써 발생합니다. 내장 구조는 신전(늘어남), 염증, 허혈에 매우 민감하지만, 작열감이나 절단감 등 종종 통증을 유발하는 다른 자극에 대해서는 중간 정도의 민감도만을 보입니다. 내장통의 증상으로는 구토, 메스꺼움, 생체 징후의 변화, 그리고 정서적 증상 등이 있습니다. 프레가발린이나 가바펜틴 등은 내장통 치료에 사용되는 약물의 일부입니다. 내장통이란 자궁, 위, 직장, 방광 등의 내장에 염증이 생겨 발생하는 내부 통증을 말합니다. 이러한 염증은 감염, 외상, 그리고 외부 또는 내부에서 비롯된 내장 손상 등 여러 요인에 의해 유발됩니다. 내장통의 강도는 다양하며, 날카로운 통증, 지속적인 통증, 혹은 때때로 몸 깊은 곳에서 밀려오는 듯한 통증 등이 있습니다.
시장 역학
내장통의 치료법이 늘어나고 있는 것이 세계 내장통 치료 시장의 성장을 견인할 것으로 예측됩니다. 예를 들어, 2022년 12월 31일 『American Journal of Physiology』지에 게재된 기사에 따르면, 만성 통증에 대한 효과적인 치료법은 거의 없는 것으로 알려져 있습니다. 오피오이드 위기는 만성 통증의 기전을 규명하고, 오피오이드와 같은 용납할 수 없는 부작용을 동반하지 않는 새로운 치료법을 개발하는 것이 시급하다는 점을 여실히 보여주고 있습니다. 급성 통증은 부상을 인식하고 피할 수 있게 해주기 때문에 생존에 필수적인 생리적 과정입니다. 만성 통증은 질환(예 : 암, 염증성 질환, 기능성 위장 장애, 당뇨병), 외상(예 : 신경 외상), 치료(예 : 화학요법)에 따라 발생할 수 있으며, 환자가 회복된 후에도 지속될 수 있습니다. 내장 기관의 경우, 통각 수용체가 다른 장기만큼 밀집되어 있지 않고 균일하게 분포되어 있지도 않기 때문에 통증의 원인을 파악하고 치료하는 것이 훨씬 더 어려워집니다.
본 조사의 주요 특징 :
- 본 조사에서는 다양한 부문의 잠재적 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 세계 내장통 치료 시장의 주요 기업 프로파일을 소개했습니다.
- 본 조사에서 다룬 주요 기업으로는 Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.가 포함됩니다.
- 본 보고서에서 얻을 수 있는 인사이트는 각 기업의 마케팅 담당자 및 경영진이 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내리는 데 도움이 될 것입니다.
- 이 책 '세계의 내장통 치료 시장 보고서'는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계의 내장통 치료 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적 및 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 내장통 치료 시장 : 약제 유형별(2021-2033년)
제5장 세계의 내장통 치료 시장 : 적응증별(2021-2033년)
제6장 세계의 내장통 치료 시장 : 유통 채널별(2021-2033년)
제7장 세계의 내장통 치료 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJY 26.07.09Visceral Pain Treatment Market is estimated to be valued at USD 17.04 Bn in 2026 and is expected to reach USD 25.45 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 17.04 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.90% | 2033 Value Projection: | USD 25.45 Bn |
Visceral pain results from the activation of nociceptors in the viscera (organs) of the pelvis, chest, or abdomen. Visceral structures are very sensitive to stretching (stretching), inflammation, and ischemia, but moderately sensitive to other stimuli that often cause pain such as burning or cutting. Symptoms of visceral pain include vomiting, nausea, changes in vital signs, and emotional manifestations. Pregabalin or gabapentin are some drugs used to treat visceral pain. Visceral pain is defined as internal pain caused by inflammation of internal organs such as the uterus, stomach, rectum, and bladder. This inflammation is caused by several factors such as infection, trauma, and external or internal injuries to internal organs. Visceral pain varies in intensity from sharp, constant, or occasionally deep, like urgent at the body.
Market Dynamics
Increasing number of treatments of visceral pain are expected to drive the global visceral pain treatment market growth. For instance, on December 31, 2022, American Journal of Physiology published an article stating there are few effective treatments for chronic pain. The opioid crisis emphasizes the urgent need to clarify the mechanisms of chronic pain and to develop new forms of treatment that do not have the unacceptable side effects of opioids. Acute pain is a physiological process that is necessary for survival because it allows the awareness and avoidance of injury. Chronic pain can accompany disease (e.g., cancer, inflammatory diseases, functional GI disorders, and diabetes), injury (e.g., neurotrauma) and therapy (e.g., chemotherapy), and can persist after patient the patient is healed. In the visceral organs, pain receptors are not as closely packed and not as evenly spread out as in other organs, which makes the pain's origin much harder to pinpoint and treat.
Key features of the study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global visceral pain treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered as a part of this study include Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global visceral pain treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visceral pain treatment market
Detailed Segmentation:
- Global Visceral Pain Treatment Market, By Drug Type (Revenue, USD Bn, 2021 - 2033)
- Pain modifiers
- Tricyclic Anticonvulsant
- Tricyclic Antidepressants
- Analgesics
- Narcotics
- NSAID
- Others
- Global Visceral Pain Treatment Market, By Indication (Revenue, USD Bn, 2021 - 2033)
- Chronic Prostatitis
- Interstitial Cystitis
- Crohn's Disease
- Irritable Bowel Syndrome
- Global Visceral Pain Treatment Market, By Distribution Channel (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacy
- Retail Pharmacy
- Online Channels
- Global Visceral Pain Treatment Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
- Company Profiles
- Addex Therapeutics Ltd.
- AstraZeneca
- Astellas Pharma Inc.
- Allergan
- Chromocell Corporation
- Takeda
- GIcare Pharma Inc.
- Abbvie
- Grunenthal GmbH
- Johnson & Johnson
- Neurim Pharmaceuticals Ltd
- Medestea Research & Production S.p.A
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Visceral Pain Treatment Market, By Drug Type, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Pain modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Tricyclic Anticonvulsant
- Tricyclic Antidepressants
- Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Narcotics
- NSAID
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
5. Global Visceral Pain Treatment Market, By Indication , 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Chronic Prostatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Interstitial Cystitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Crohn's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
6. Global Visceral Pain Treatment Market, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
- Online Channels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Billion)
7. Global Visceral Pain Treatment Market, By Region, 2021 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021-2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2021 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021-2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Addex Therapeutics Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Chromocell Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GIcare Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbvie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Neurim Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medestea Research & Production S.p.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
